Drawing for INDERO CRO

USPTO serial 79412141

INDERO CRO

Reviewed by CopyMark Law Group

Reg. 8258151Status 700Registered
Filing date
Status date
Registration date
May 19, 2026
Examiner
DRUHAN, CONNOR M
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with INDERO CRO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles G. Zug

Charles G. Zug Nelson Mullins Riley & Scarborough LLP301 S. College St.Suite 2300, IP DepartmentCharlotte, NC 28202

Goods and services

ClassDescriptionStatusFirst use
035Distributorship services for others in the fields of cameras and imaging equipment for use in the field of dermatology and laboratory equipment for use in the field of clinical research; electronic data collection services for business purposes in the field of preclinical and nonclinical research, clinical trials and technical studies related to pharmaceutical and biological drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; collection and compilation of information into computer databases in the field of preclinical and nonclinical research, clinical trials and technical studies related to pharmaceutical and biological drugs for human and veterinary useACTIVE—
042Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information on the design and management of clinical trials; Scientific research in relation to the design and management of clinical trials and development of clinical trials in the fields of pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; Medical and scientific research, namely, designing, developing protocols for, organizing, conducting, monitoring, and managing clinical trials and preclinical and nonclinical research studies, research support services and research project management services in relation to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products for others; Consulting services for others in the field of medical and scientific research, namely, clinical trials and preclinical and nonclinical research studies, research support services and research project management services in relation to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; Calibration services, namely, the calibration of electronic data for the purpose of conducting clinical trials and preclinical and nonclinical research studies related to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; Electronic storage of data in the field of clinical trials and preclinical and nonclinical research studies related to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; Medical research services, namely, research assistance services and research project management services for the purpose of designing and conducting clinical trials in relation to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; Scientific research in relation to the designing and conducting of clinical trials in the fields of data management and biostatistics; Providing scientific information on the design and management of clinical trials and preclinical and nonclinical research studies; Research assistance services and research project management services for the purpose of designing and conducting clinical trials in relation to pharmaceutical and biologic drugs for human and veterinary use, natural health products, and medical devicesACTIVE—
044Medical testing services in relation to subjects in clinical trials of pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic productsACTIVE—
045Regulatory compliance consulting and advisory services in relation to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 19, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 28, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 19, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 19, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 19, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 11, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 11, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 31, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 31, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 25, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 6, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 5, 2026UNTDREQUEST TO DIVIDE UNTIMELY, REFUSED, OR WITHDRAWN—
Feb 26, 2026IROARESPONSE TO ITU OFFICE ACTION ENTERED—
Feb 26, 2026PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Feb 25, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 20, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Feb 20, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 20, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 20, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 10, 2026ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Sep 9, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 9, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 9, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 15, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 15, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 15, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 8, 2025RFNTREFUSAL PROCESSED BY IB—
Feb 18, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 18, 2025RFRRREFUSAL PROCESSED BY MPU—
Jan 7, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 6, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 26, 2024DOCKASSIGNED TO EXAMINER—
Dec 13, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 13, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 12, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance